Viruses |
Adenovirus |
Highly efficient transduction profile111
|
Immunological responses, nonspecific cell targetting,111 acute toxicity151
|
AAV |
Highly efficient transduction profile,111 reduce inflammatory and immune responses152, 153
|
Requires helper virus,152 small cloning capacity154
|
Retrovirus |
High gene transduction |
Dependence of cell differentiated state,155 insertion into host genomes115
|
Lentivirus |
High gene transduction, cell differentiated state independence156
|
Insertion into host genomes115
|
Lipids |
Cationic |
Good transfection efficiency, electrostatic interactions with siRNA115
|
Poor stability, cellular toxicity, immune response elicitation106, 157
|
Neutral |
Reduced cytotoxicity115
|
Reduced ability to complex with siRNA115
|
Nanoparticles |
Charge variable, complex formation prior to administration, neutralized at physiological pH, reduced toxicity and immunological responses, increased membrane destabilizing capacity, higher endosomolytic activity110, 115, 158
|
Synthetic challenges |
Polymers |
Polycations |
Modifiable size115
|
Weaker interactions with siRNA115
|
Nanoparticles |
Biocompatible, biodegradable, synthetic diversity115
|
Large surface area causes aggregation159
|
Peptides |
PLL |
Electrostatic interactions with siRNA, synthetic diversity120
|
Toxicity, nonspecific binding, poor endosomal escape102, 160, 161
|
CPPs |
Synthetic diversity, covalent and noncovalent complex formation120
|
Membrane permeability challenges, poor endosomal escape120, 162
|